Los Angeles Capital Management
IMNM icon

Los Angeles Capital Management’s Immunome IMNM Stock Holding History

Los Angeles Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181K Sell
8,281
-51,136
-86% -$1.14M ﹤0.01% 1172
2025
Q4 		$949K Sell
59,417
-27,685
-32% -$486K ﹤0.01% 643
2025
Q3 		$1.02M Buy
87,102
+45,245
+108% +$450K ﹤0.01% 702
2025
Q2 		$389K Buy
41,857
+6,009
+17% +$49.3K ﹤0.01% 954
2025
Q1 		$241K Buy
35,848
+127
+0.4% +$1.22K ﹤0.01% 962
2024
Q4 		$379K Buy
+35,721
New +$432K ﹤0.01% 878

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Los Angeles Capital Management's IMNM Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Immunome (IMNM) stake by 86% in Q1 2026, selling an estimated $1.14M and leaving 8,281 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Los Angeles Capital Management first reported a position in IMNM in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.02M in Q3 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Los Angeles Capital Management held 8,281 shares of Immunome worth $181K as of Q1 2026.
  • Los Angeles Capital Management sold 51,136 Immunome shares in Q1 2026, an estimated $1.14M.
  • Immunome made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1172 holding.
  • Los Angeles Capital Management first reported a position in Immunome in Q4 2024 and has held it in 6 quarters since.
  • Los Angeles Capital Management's Immunome position peaked at $1.02M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.